Luo Qi-Zhi, Li Li-Xin, Xie Yu-Bin, Yan Mei-Yu, Yu Ping
Department of Immunology, Xiangya School of Medicine, Central South University, Changsha 410008, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):1016-8.
To investigate the association of HLA-A, B, and DRB1 alleles with leukemia in the Han population in Hunan Province.
HLA-A, B, and DRB1 alleles were genotyped in 105 patients with chronic myelocytic leukemia, 25 with acute lymphocytic leukaemia, and 48 with acute nonlymphocytic leukemia using polymerase chain reaction with sequence-specific primer (PCR-SSP). The hemopoietic stem cells from 3,664 unrelated normal individuals of Han nationality in Hunan were used as the control group.
The phenotypic frequencies of HLA-B58, DR12, and DR14 were significantly higher in patients with chronic myelocytic leukemia than in the control group, with relative risk of 6.1287, 1.6519, and 1.6479, respectively. In patients with acute lymphocytic leukaemia, the phenotypic frequency of HLA-B58 was significantly higher than that in the control group, with the relative risk of 7.4055. In patients with acute nonlymphocytic leukemia, the frequencies of HLA-B58 and DR8 phenotypes were significantly higher but HLA-A24 frequency was significantly lower than those of the control group, with the relative risk of 13.9789, 2.2839, and 0.4012, respectively.
HLA-B58, DR12, DR14 alleles appear to contribute to the genetic susceptibility of patients with chronic myelocytic leukemia. HLA-B58 allele can be associated with the genetic susceptibility for patients with acute lymphocytic leukaemia. In patients with acute nonlymphocytic leukemia, HLA-B58 and DR8 are probably the susceptible alleles whereas HLA-A24 allele may play a protective role.
探讨HLA - A、B及DRB1等位基因与湖南省汉族人群白血病的相关性。
采用序列特异性引物聚合酶链反应(PCR - SSP)对105例慢性粒细胞白血病患者、25例急性淋巴细胞白血病患者及48例急性非淋巴细胞白血病患者进行HLA - A、B及DRB1等位基因分型。选取3664名湖南省汉族无关正常个体的造血干细胞作为对照组。
慢性粒细胞白血病患者中HLA - B58、DR12及DR14的表型频率显著高于对照组,相对风险分别为6.1287、1.6519和1.6479。急性淋巴细胞白血病患者中,HLA - B58的表型频率显著高于对照组,相对风险为7.4055。急性非淋巴细胞白血病患者中,HLA - B58和DR8表型频率显著高于对照组,但HLA - A24频率显著低于对照组,相对风险分别为13.9789、2.2839和0.4012。
HLA - B58、DR12、DR14等位基因似乎与慢性粒细胞白血病患者的遗传易感性有关。HLA - B58等位基因可能与急性淋巴细胞白血病患者的遗传易感性相关。对于急性非淋巴细胞白血病患者,HLA - B58和DR8可能是易感等位基因,而HLA - A24等位基因可能起保护作用。